How Was This Not Planned In Advance? Ebola Vaccine Magically Ready For Human Trials In Weeks, Not Years

Jonathan Benson

(NaturalNews) More proof that the West African Ebola crisis is a total fraud lies in a newly proposed Ebola vaccine that just so conveniently awaits human trials in a matter of weeks, not years. Researchers at Oxford University in the UK are ready to begin testing the vaccine, which seems to have magically appeared out of nowhere, with plans to administer it to some 10,000 health workers by the end of the year.

A product of drug giant GlaxoSmithKline (GSK) in partnership with the U.S. National Institutes of Health (NIH), the experimental vaccine is now being fast-tracked amid hype and panic over what the media claims is the worst Ebola outbreak in history. Since the world is now in “crisis” mode, the vaccine will most likely avoid having to undergo the normal safety testing process and instead be rushed to market for quick profits.

According to BBC News, it normally takes several years for a new vaccine to hit the market. Extensive trials, first on animals and then on humans, are a normal part of the vaccine development process, a process that helps ensure that a vaccine won’t harm humans and actually provides the stated benefits.

But for Ebola, it appears that only minimal testing will take place on just 60 healthy volunteers, all of whom will be injected with genetic material derived from both Ebola and a common cold virus that typically afflicts chimpanzees. The two components are supposedly safe — of course they are, GSK — and do not pose any risk of infection.

“This is a remarkable example of how quickly a new vaccine can be progressed into the clinic, using international co-operation,” stated Professor Adrian Hill, director of Oxford’s Jenner Institute, and lead author of the trial.

Read More Here